CHORNOMAZ v. BRISTOL-MYERS SQUIB COMPANY

CourtDistrict Court, D. New Jersey
DecidedJuly 5, 2023
Docket3:22-cv-05283
StatusUnknown

This text of CHORNOMAZ v. BRISTOL-MYERS SQUIB COMPANY (CHORNOMAZ v. BRISTOL-MYERS SQUIB COMPANY) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
CHORNOMAZ v. BRISTOL-MYERS SQUIB COMPANY, (D.N.J. 2023).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

OKSANA CHORNOMAZ, Plaintiff, Civil Action No. 22-5283 (MAS) (RLS) MEMORANDUM OPINION BRISTOL-MYERS SQUIB COMPANY et al., Defendants.

SHIPP, District Judge This matter comes before the Court on a Motion to Compel Arbitration and Stay Proceedings Pending Arbitration filed by Defendant Bristol-Myers Squib Company (“Defendant” or “BMS”). (ECF No. 10.) Plaintiff Oksana Chornomaz (“Plaintiff’ or “Chornomaz”) opposed (ECF No, 22), and Defendant replied (ECF No. 26). The Court has carefully considered the parties’ submissions and decides the Motion without oral argument pursuant to Local Civil Rule 78.1. For the reasons set forth below, Defendant’s Motion is granted. I. BACKGROUND This case arises out of Plaintiff’s employment with BMS from April 2020 until December (Am. Compl. {f 27, 58, ECF No. 4.) In April 2020, Plaintiff was hired by BMS as an Executive Associate. (ld. § 27.) As part of Plaintiffs hiring process, and in accordance with BMS’s arbitration policy and program, Plaintiff was given a copy of the BMS Mutual Arbitration Agreement, dated January 2020

(“Arbitration Agreement”). (Decl. of Susan Small (“Small Decl.”) 49 2-4, ECF No. 10-2; see also Decl. of Mary Beth Nagy 4, 5, ECF No. 10-3.) According to Defendant’s records, on April 24, 2020, Plaintiff reviewed and electronically signed the Arbitration Agreement uploaded to her account on BMS’s onboarding platform. (Small Decl. 4 5; Small Decl. Ex. B, ECF No. 10-2.) In doing so, Plaintiff accepted the following terms regarding resolving employment-related disputes by arbitration: [A]ll disputes, claims, complaints, or controversies (“Claims”) that you have now, or at any time in the future may have, against Bristol-Myers Squibb Company and/or any of its parents, subsidiaries, affiliates, predecessors, successors, assigns, current, former, or future officers, directors, employees, and/or those acting as an agent of the Company (which make up the definition of the “Company ”), or that the Company has now or at any time in the future may have against you (“Covered Claims”), arising out of and/or related to your application for employment with the Company, your employment with the Company, and/or the termination of your employment with the Company will be resolved by arbitration and NOT by a court or jury.

THE PARTIES HEREBY FOREVER WAIVE AND GIVE UP THE RIGHT TO HAVE A JUDGE OR A JURY DECIDE ANY COVERED CLAIMS. (Mutual Arbitration Agreement (“Agrmt.”) J 1.a., Small Decl., Ex. A; ECF No. 10-2.) At the end of the Arbitration Agreement, it further explained: You understand that your affirmative signature of this Agreement is not required for the Agreement to be enforced. If you commence work for the Company without signing this Agreement, this Agreement will be effective, and you will have agreed to, ratified and accepted this Agreement through your knowledge of it and your acceptance of and continued employment with the Company. Ud. 47.) On September 7, 2021, in connection with the novel coronavirus (“COVID-19”) pandemic, BMS announced a revision to its company policy requiring employees to be fully vaccinated against COVID-19 by November 1, 2021 (““COVID-19 Vaccination Policy”). (Am. Compl. { 30.) As part of BMS’s rollout of the policy, it also stated that it would terminate “for cause” those

ry

employees who did not comply with the COVID-19 Vaccination Policy. (/d. § 31.) The policy also included an exception provision, allowing BMS to accept and consider individual employees’ requests for medical or religious accommodation. (/d. § 32.) To apply for religious accommodation from the COVID-19 Vaccination Policy, BMS employees were required to complete a request form, which asked employees to identify “what their religious beliefs were, how [those beliefs] conflicted with the policy, the duration of the requested accommodation, and what accommodation they desired.” (/d. | 40.) On September 30, 2021, Plaintiff submitted a request form for a religious accommodation from the COVID-19 Vaccination Policy, claiming that her sincerely held religious beliefs precluded her from being vaccinated against COVID-19. Ud. { 42.) Plaintiff's objections to the COVID-19 vaccine were based on her religious affiliation with the “Ukrainian Greek Catholic Church, an Eastern Catholic Church of the Byzantine Rite.” (/d.) She explained to BMS that she did not object to traditional medicine or traditional vaccines, but instead, objected to “the technology utilized in the available Covid vaccines.” Ud. {9 45-46.) Specifically, she objected to “mRNA/viral vectored vaccine technology, spike protein technology, the use of fetal stem cells or genetically modified, artificially preserved, or ‘immortalized human cell lines’ as being against God’s Will and the beliefs of her church.” Ud. § 43.) In correspondence dated November 18, 2021, to Plaintiff from Defendant Caitlin Freeland (“Freeland”), Executive Director of Human Resources for BMS, BMS denied Plaintiffs request for religious accommodation. (/d. f§ 20, 47, 58.) BMS did so on the grounds that “Plaintiff did not sincerely hold a religious belief that precluded her from receiving the COVID-19 vaccination” and that “any reasonable accommodation, such as to work remotely, would result in an undue burden to BMS.” (Ud. {| 48.) Subsequently, because Plaintiff did not receive any COVID-19 vaccine, she was involuntarily terminated by BMS on or about December 6, 2021. (id. § 58.)

Thereafter, Plaintiff initiated the present lawsuit against Defendants BMS and Freeland (together, “Defendants’”) on August 29, 2022. (ECF No. 1.) On September 8, 2022, Plaintiff amended her complaint, asserting six causes of action for religious discrimination: (1) failure to accommodate under the New Jersey Law Against Discrimination, N.J.S.A. §§ 10:5-12 et seg. (the “NJLAD”) (Count One); (2) wrongful termination under the NJLAD (Count Two); (3) aiding and abetting by Freeland in violation of the NJLAD (Count Three); (4) failure to accommodate under “Title XII” of the Civil Rights Act of 1964, 42 U.S.C. § 2000e ef seg. (the “Civil Rights Act’) (Count Four);! (5) wrongful termination under “Title XH” of the Civil Rights Act (Count Five); and (6) declaratory judgment voiding the COVID-19 Vaccination Policy under the New Jersey Declaratory Judgment Act, N.J.S.A. §§ 2A:16-50 et seq., and the Federal Declaratory Judgment Act, 28 U.S.C. §§ 2201-2202 (Count Six). (Am. Compl. 12-36.) In lieu of filing an answer, Defendant BMS now moves to compel arbitration pursuant to the Federal Arbitration Act, 9 U.S.C. §§ 3 and 4 (the “FAA”), arguing that the Arbitration Agreement compels Plaintiff to arbitrate all claims related to her employment with Defendant, including all those asserted in the Amended Complaint. (Def.’s Moving Br. 5, ECF No. 10-1.) Il. LEGAL STANDARD “The FAA declares that ‘[a] written provision in any ... contract... to settle by arbitration

... Shall be valid, irrevocable, and enforceable, save upon such grounds as exist at law or in equity for the revocation of any contract.’” Preziosi v. JetSmarter, Inc., No. 19-13627, 2020 WL 978637, at *2 (D.N.J. Feb. 28, 2020) (quoting 9 U.S.C. § 2). Because arbitration is a matter of contract,

' Plaintiff asserts claims under “Title XII” of the Civil Rights Act in Counts Four and Five. (Am. Compl.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Guidotti v. Legal Helpers Debt Resolution, L.L.C.
716 F.3d 764 (Third Circuit, 2013)
Kirleis v. Dickie, McCamey & Chilcote, P.C.
560 F.3d 156 (Third Circuit, 2009)
Martindale v. Sandvik, Inc.
800 A.2d 872 (Supreme Court of New Jersey, 2002)
Singer v. Commodities Corp.
678 A.2d 1165 (New Jersey Superior Court App Division, 1996)
Leodori v. Cigna Corp.
814 A.2d 1098 (Supreme Court of New Jersey, 2003)
Patricia Atalese v. U.S. Legal Services Group, L.P. (072314)
99 A.3d 306 (Supreme Court of New Jersey, 2014)
Flintkote Co. v. Aviva PLC
769 F.3d 215 (Third Circuit, 2014)
Varallo v. Elkins Park Hospital
63 F. App'x 601 (Third Circuit, 2003)
Young v. Prudential Insurance Co. of America, Inc.
688 A.2d 1069 (New Jersey Superior Court App Division, 1997)
Jaworski v. Ernst & Young U.S. LLP
119 A.3d 939 (New Jersey Superior Court App Division, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
CHORNOMAZ v. BRISTOL-MYERS SQUIB COMPANY, Counsel Stack Legal Research, https://law.counselstack.com/opinion/chornomaz-v-bristol-myers-squib-company-njd-2023.